Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 51.76%-464.73K | -62.13%-2.17M | -289.82%-2.42M | 30.95%-4.25M | 1.93%-1.32M | 43.88%-963.28K | 31.32%-1.34M | 45.19%-621.56K | 48.93%-6.15M | 75.24%-1.35M |
| Net income from continuing operations | -30.51%-1.63M | 91.05%-143.82K | -480.48%-1.41M | 36.80%-4.44M | -9.89%-1.34M | -12.51%-1.25M | 7.14%-1.61M | 91.83%-242.32K | 31.59%-7.03M | 66.73%-1.22M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --15.45K | --26.2K |
| Depreciation and amortization | -18.97%37.1K | -31.48%36.74K | -33.75%35.52K | -14.62%187.07K | -36.16%34.06K | -16.87%45.78K | -4.66%53.62K | -1.54%53.62K | 2.91%219.11K | -7.43%53.35K |
| Remuneration paid in stock | 3.06%110.4K | -9.31%289.48K | 671.66%67.91K | -18.12%507.86K | -25.64%72.73K | 251.53%107.13K | 91.96%319.21K | -97.94%8.8K | -56.28%620.26K | -50.37%97.8K |
| Other non cashItems | -441.55%-250.34K | -9,288.53%-967.19K | -13,436.85%-1.19M | -41.13%107.94K | 118.75%15.19K | -8.22%73.29K | -82.14%10.53K | -92.89%8.93K | 107.29%183.37K | 93.40%-81.03K |
| Change In working capital | 1,913.68%1.27M | -1,091.96%-1.39M | 115.85%71.4K | -287.86%-605.47K | 54.39%-101.58K | 109.48%63.22K | 76.31%-116.52K | -136.77%-450.59K | 82.24%-156.1K | 72.07%-222.7K |
| -Change in receivables | 1,952.58%945.85K | -63,320.35%-727.03K | -32,476.20%-169.72K | -175.22%-282.12K | -2,014.39%-266.92K | -87.88%46.08K | 103.13%1.15K | -101.18%-521 | 178.34%375.05K | 91.67%-12.62K |
| -Change in payables and accrued expense | 387.90%258.02K | -189.31%-386.89K | 170.43%241.74K | -414.73%-530.4K | 64.82%-168.23K | 108.95%52.88K | -146.62%-133.73K | -150.55%-343.24K | 54.57%-103.04K | 14.47%-478.23K |
| -Change in other current assets | 306.20%69.14K | -57.90%14.57K | 100.24%249 | 171.58%235.51K | 30.37%337.02K | 80.88%-33.53K | 108.30%34.62K | -2,132.09%-102.6K | ---329K | --258.52K |
| -Change in other working capital | --0 | -1,459.71%-289.54K | 79.39%-871 | 71.29%-28.45K | -135.77%-3.45K | 99.21%-2.21K | 94.28%-18.56K | -100.85%-4.23K | -230.25%-99.11K | -84.98%9.64K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 51.76%-464.73K | -62.13%-2.17M | -289.82%-2.42M | 30.95%-4.25M | 1.93%-1.32M | 43.88%-963.28K | 31.32%-1.34M | 45.19%-621.56K | 48.93%-6.15M | 75.24%-1.35M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -2.7K | 0 | 207.10%61.91K | -104.43%-15.48K | -4.69K | 0 | 115.88%82.08K | -24.33%-57.81K | 349.33K |
| Net PPE purchase and sale | --0 | ---2.7K | --0 | -371.38%-23.47K | -278.97%-15.48K | ---4.69K | --0 | ---3.3K | 118.60%8.65K | --8.65K |
| Net investment purchase and sale | --0 | --0 | --0 | 228.48%85.38K | --0 | --0 | --0 | 116.52%85.38K | ---66.46K | --340.68K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---2.7K | --0 | 207.10%61.91K | -104.43%-15.48K | ---4.69K | --0 | 115.88%82.08K | -24.33%-57.81K | --349.33K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 9,087.56%4.81M | -101.08%-42.66K | 56.13%-40.34K | 4,032.34%8.72M | 8,524.16%4.93M | 8.39%-53.57K | 6,846.07%3.94M | -97.96%-91.97K | -282.22%-221.87K | 3.78%-58.47K |
| Net issuance payments of debt | 12.11%-47.3K | 31.16%-42.66K | 56.13%-40.34K | -4.87%-245.28K | -15.48%-67.53K | 7.96%-53.82K | -5.98%-61.97K | -57.28%-91.97K | -4.86%-233.89K | 3.78%-58.47K |
| Net common stock issuance | ---- | ---- | ---- | --8.97M | ---- | ---- | --4.01M | ---- | --0 | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --30K | --0 | ---- | --0 | -92.72%12.01K | --0 |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | --251 | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 9,087.56%4.81M | -101.08%-42.66K | 56.13%-40.34K | 4,032.34%8.72M | 8,524.16%4.93M | 8.39%-53.57K | 6,846.07%3.94M | -97.96%-91.97K | -282.22%-221.87K | 3.78%-58.47K |
| Net cash flow | ||||||||||
| Beginning cash position | -39.90%3.19M | 100.40%5.4M | 136.39%7.87M | -65.89%3.33M | -2.41%4.28M | -13.94%5.3M | -66.54%2.7M | -65.89%3.33M | -55.45%9.76M | -71.27%4.38M |
| Current changes in cash | 525.80%4.35M | -185.22%-2.22M | -290.10%-2.46M | 170.61%4.54M | 439.68%3.59M | 42.44%-1.02M | 236.98%2.6M | 62.80%-631.44K | 47.07%-6.43M | 80.80%-1.06M |
| End cash Position | 76.09%7.54M | -39.90%3.19M | 100.40%5.4M | 136.39%7.87M | 136.39%7.87M | -2.41%4.28M | -13.94%5.3M | -66.54%2.7M | -65.89%3.33M | -65.89%3.33M |
| Free cash from | 51.99%-464.73K | -62.33%-2.18M | -287.76%-2.42M | 30.64%-4.27M | 1.28%-1.34M | 43.60%-967.98K | 31.32%-1.34M | 44.90%-624.86K | 49.07%-6.16M | 75.11%-1.35M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.